BRL 8.87
(-0.23%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 406.06 Million BRL | 37.03% |
2022 | 326.76 Million BRL | 78.98% |
2021 | 189.46 Million BRL | 0.92% |
2020 | 107.21 Million BRL | 191.46% |
2019 | 64.27 Million BRL | 109.36% |
2018 | 30.89 Million BRL | -25.57% |
2017 | 39.82 Million BRL | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 112.93 Million BRL | -3.37% |
2024 Q2 | 70.25 Million BRL | -12.29% |
2023 Q4 | 122.22 Million BRL | 5.29% |
2023 FY | - BRL | 37.03% |
2023 Q3 | 116.07 Million BRL | 1.01% |
2023 Q2 | 114.91 Million BRL | 34.68% |
2023 Q1 | 85.32 Million BRL | 57.39% |
2022 Q3 | 86.72 Million BRL | -6.94% |
2022 Q2 | 93.19 Million BRL | 0.62% |
2022 Q1 | 92.62 Million BRL | 729.82% |
2022 FY | - BRL | 78.98% |
2022 Q4 | 54.21 Million BRL | -37.49% |
2021 FY | - BRL | 0.92% |
2021 Q2 | 70.1 Million BRL | 47.81% |
2021 Q1 | 47.42 Million BRL | -52.03% |
2021 Q4 | 11.16 Million BRL | -79.28% |
2021 Q3 | 53.87 Million BRL | -23.15% |
2020 FY | - BRL | 191.46% |
2020 Q4 | 98.87 Million BRL | 173.85% |
2020 Q3 | 36.1 Million BRL | 61.14% |
2020 Q2 | 22.4 Million BRL | 9.22% |
2020 Q1 | 20.51 Million BRL | 0.0% |
2019 FY | - BRL | 109.36% |
2018 FY | - BRL | -25.57% |
2017 FY | - BRL | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Oncoclínicas do Brasil Serviços Médicos S.A. | 1.16 Billion BRL | 65.234% |
Rede D'Or São Luiz S.A. | 10.25 Billion BRL | 96.039% |